Spots Global Cancer Trial Database for cognitive assessment
Every month we try and update this database with for cognitive assessment cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Serial Testing To Assess Cognitive Function In Cancer | NCT06160700 | Cancer | Montreal Cognit... | 18 Years - | Indiana University | |
| Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors | NCT03194906 | Glioma of Brain Craniopharyngio... Ependymoma Germ Cell Tumor | Memantine Placebo Cognitive Asses... | 6 Years - 21 Years | St. Jude Children's Research Hospital | |
| Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia | NCT02336282 | Acute Lymphobla... | transcranial Di... Sham Cognitive Asses... Brain Games Sti... | 18 Years - | St. Jude Children's Research Hospital | |
| Bevacizumab and Lomustine for Recurrent GBM | NCT01290939 | Glioblastoma Mu... Cognition Disor... Disability Eval... | bevacizumab lomustine DNA methylation... laboratory biom... cognitive asses... quality-of-life... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Bevacizumab and Lomustine for Recurrent GBM | NCT01290939 | Glioblastoma Mu... Cognition Disor... Disability Eval... | bevacizumab lomustine DNA methylation... laboratory biom... cognitive asses... quality-of-life... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Fatigue in Breast Cancer Survivors | NCT00972400 | Breast Cancer Cancer Survivor Fatigue Psychosocial Ef... | protein analysi... laboratory biom... mass spectromet... questionnaire a... assessment of t... cognitive asses... quality-of-life... | - | National Cancer Institute (NCI) | |
| Systematic Light Exposure in Pediatric Brain Tumor Survivors | NCT05340881 | Brain Tumor | Bright Light Ex... Dim Light Expos... Cognitive Asses... | 10 Years - 18 Years | Baylor College of Medicine | |
| Systematic Light Exposure in Pediatric Brain Tumor Survivors | NCT05340881 | Brain Tumor | Bright Light Ex... Dim Light Expos... Cognitive Asses... | 10 Years - 18 Years | Baylor College of Medicine | |
| Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor | NCT00070161 | Brain and Centr... Radiation Toxic... | EGb761 donepezil hydro... cognitive asses... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Bevacizumab and Lomustine for Recurrent GBM | NCT01290939 | Glioblastoma Mu... Cognition Disor... Disability Eval... | bevacizumab lomustine DNA methylation... laboratory biom... cognitive asses... quality-of-life... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia | NCT00437060 | Childhood B Acu... Childhood T Acu... Cognitive Side ... Long-Term Effec... Neurotoxicity S... Psychological I... Untreated Child... | Cognitive Asses... Diffusion Tenso... Laboratory Biom... Pharmacological... Psychosocial As... | 1 Year - 17 Years | Children's Oncology Group | |
| Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases | NCT01843413 | Tumors Metastat... Unspecified Adu... | stereotactic ra... quality-of-life... cognitive asses... | 18 Years - | Case Comprehensive Cancer Center | |
| 7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy | NCT06191575 | Hypogonadism Malignant Testi... | 7 Tesla Magneti... Biospecimen Col... Cognitive Asses... | 18 Years - | University of Southern California | |
| Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). | NCT05961644 | Multiple Sclero... Multiple Sclero... | Cladribine Subc... 0.9% Chloride I... | 30 Years - 65 Years | Institute of Psychiatry and Neurology, Warsaw | |
| Work Ability in Young Adult Cancer Survivors | NCT03148080 | Cancer Survivor | Cognitive Asses... Questionnaire A... | 25 Years - 34 Years | Wake Forest University Health Sciences | |
| Work Ability in Young Adult Cancer Survivors | NCT03148080 | Cancer Survivor | Cognitive Asses... Questionnaire A... | 25 Years - 34 Years | Wake Forest University Health Sciences | |
| Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery | NCT03184038 | Metastatic Mali... Metastatic Mali... | Cognitive Asses... Stereotactic Ra... Stereotactic Bo... Quality-of-Life... | 18 Years - | Thomas Jefferson University | |
| 7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy | NCT06191575 | Hypogonadism Malignant Testi... | 7 Tesla Magneti... Biospecimen Col... Cognitive Asses... | 18 Years - | University of Southern California | |
| Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer | NCT00126477 | Leukemia Lymphoma Myelodysplastic... Quality of Life | cognitive asses... management of t... psychosocial as... quality-of-life... | 18 Years - | Fred Hutchinson Cancer Center | |
| Screening Tools to Predict Treatment Outcome in Older Cancer Patients Who Are Undergoing Treatment | NCT01005693 | Unspecified Adu... | questionnaire a... cognitive asses... examination management of t... | 65 Years - | National Cancer Institute (NCI) | |
| Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy | NCT00681928 | Breast Cancer | anastrozole letrozole questionnaire a... cognitive asses... psychosocial as... | 65 Years - | City of Hope Medical Center | |
| Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy | NCT00681928 | Breast Cancer | anastrozole letrozole questionnaire a... cognitive asses... psychosocial as... | 65 Years - | City of Hope Medical Center | |
| Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery | NCT03184038 | Metastatic Mali... Metastatic Mali... | Cognitive Asses... Stereotactic Ra... Stereotactic Bo... Quality-of-Life... | 18 Years - | Thomas Jefferson University | |
| Memory Neuroimaging in Children, Adolescents and Young Adults Following Pediatric Cancer | NCT04324450 | Cancer Brain Pediatric Cance... | MRI Cognitive asses... | - | Institut National de la Santé Et de la Recherche Médicale, France | |
| Bioenergetic Profiling and Cognition in GBM Patients | NCT03939858 | Glioblastoma | Cognitive Asses... Blood Collectio... Bioenergetic Pr... | 18 Years - | Wake Forest University Health Sciences | |
| Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy | NCT01506440 | Malignant Neopl... Unspecified Adu... | cognitive asses... quality-of-life... | 50 Years - | Wake Forest University Health Sciences | |
| Systematic Light Exposure in Pediatric Brain Tumor Survivors | NCT05340881 | Brain Tumor | Bright Light Ex... Dim Light Expos... Cognitive Asses... | 10 Years - 18 Years | Baylor College of Medicine | |
| Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy | NCT01506440 | Malignant Neopl... Unspecified Adu... | cognitive asses... quality-of-life... | 50 Years - | Wake Forest University Health Sciences | |
| Neuropsychological and Behavioral Testing in Younger Patients With Cancer | NCT00772200 | Childhood Malig... | Cognitive Asses... Quality-of-Life... | 1 Month - | Children's Oncology Group | |
| Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery | NCT03184038 | Metastatic Mali... Metastatic Mali... | Cognitive Asses... Stereotactic Ra... Stereotactic Bo... Quality-of-Life... | 18 Years - | Thomas Jefferson University | |
| Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer | NCT00975897 | Colorectal Canc... | bevacizumab cetuximab fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin RNA analysis cytogenetic ana... fluorescence in... gene expression... mutation analys... protein express... diagnostic labo... immunohistochem... questionnaire a... cognitive asses... | 18 Years - | National Cancer Institute (NCI) | |
| Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases | NCT01843413 | Tumors Metastat... Unspecified Adu... | stereotactic ra... quality-of-life... cognitive asses... | 18 Years - | Case Comprehensive Cancer Center | |
| Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases | NCT01592968 | Metastatic Mali... Metastatic Mali... | Cognitive Asses... Quality-of-Life... Stereotactic Ra... Whole-Brain Rad... | 18 Years - | M.D. Anderson Cancer Center | |
| Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors | NCT03194906 | Glioma of Brain Craniopharyngio... Ependymoma Germ Cell Tumor | Memantine Placebo Cognitive Asses... | 6 Years - 21 Years | St. Jude Children's Research Hospital | |
| Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response | NCT06175000 | Primary Central... | Cognitive Asses... Obinutuzumab Quality of Life... | 18 Years - | Providence Health & Services | |
| A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for Primary Central Nervous System Tumors | NCT04939597 | Central Nervous... | Biospecimen Col... Cognitive Asses... Magnetic Resona... Memantine Hydro... Placebo Adminis... Questionnaire A... | 4 Years - 17 Years | Children's Oncology Group | |
| Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy | NCT01080521 | Cognitive Side ... Malignant Ovari... Ovarian Brenner... Ovarian Carcino... Ovarian Chorioc... Ovarian Clear C... Ovarian Dysgerm... Ovarian Embryon... Ovarian Endomet... Ovarian Mixed G... Ovarian Mucinou... Ovarian Polyemb... Ovarian Sarcoma Ovarian Seromuc... Ovarian Serous ... Ovarian Teratom... Ovarian Yolk Sa... Stage I Ovarian... Stage IA Fallop... Stage IA Ovaria... Stage IA Ovaria... Stage IB Fallop... Stage IB Ovaria... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Ovari... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIC Ovari... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Ovaria... Stage IV Primar... Undifferentiate... | Cognitive Asses... Quality-of-Life... | 18 Years - | GOG Foundation | |
| Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). | NCT05961644 | Multiple Sclero... Multiple Sclero... | Cladribine Subc... 0.9% Chloride I... | 30 Years - 65 Years | Institute of Psychiatry and Neurology, Warsaw | |
| Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer | NCT02635009 | Extensive Stage... Limited Stage S... | 3-Dimensional C... Cognitive Asses... Intensity-Modul... Laboratory Biom... Quality-of-Life... | 18 Years - | NRG Oncology | |
| Bioenergetic Profiling and Cognition in GBM Patients | NCT03939858 | Glioblastoma | Cognitive Asses... Blood Collectio... Bioenergetic Pr... | 18 Years - | Wake Forest University Health Sciences | |
| Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00731731 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... | 3-Dimensional C... Cognitive Asses... Laboratory Biom... Temozolomide Vorinostat | 18 Years - | National Cancer Institute (NCI) | |
| Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer | NCT02696993 | Metastatic Mali... Stage IV Non-Sm... | Cognitive Asses... Ipilimumab Laboratory Biom... Nivolumab Stereotactic Ra... Whole-Brain Rad... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
